NCT04995783View on ClinicalTrials.gov

Predicting Medication Response for Autoimmune Disease

TerminatedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Ulcerative ColitisCrohn's DiseasePsoriasisRheumatoid Arthritis
Interventions
DIAGNOSTIC_TEST

Coral FRS test

A novel clinical test to predict autoimmune medication response

Trial Locations (1)

94107

Coral Genomics, Inc., San Francisco

Sponsors
All Listed Sponsors
collaborator

National Human Genome Research Institute (NHGRI)

NIH

lead

Coral Genomics, Inc.

INDUSTRY